Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software & TMT
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
17 feb 2025
Equity Research Ecoclime Q4 2024: Improvement expected in 2025
Equity Research
Ecoclime
14 feb 2025
Equity Research Ecoclime, Q4 2024: Weak quarter, but expected to improve in 2025
Equity Research
Ecoclime
03 feb 2025
Equity Research Ecoclime, Q4 2024: Cash boost for Evertherm investment
Equity Research
Ecoclime
20 nov 2024
Equity Research Ecoclime, Q3 2024: October better after weak third quarter
Equity Research
Ecoclime
15 nov 2024
Equity Research Ecoclime, Q3 2024: Additional costs weigh on results
Equity Research
Ecoclime
21 aug 2024
Equity Research Ecoclime, Q2 2024: Increased focus on Evertherm sales
Equity Research
Ecoclime
16 aug 2024
Equity Research Ecoclime, Q2 2024: A result impacted by weak construction demand
Equity Research
Ecoclime
20 maj 2024
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
Equity Research
Ecoclime
16 maj 2024
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
Equity Research
Ecoclime
19 feb 2024
Equity Research Ecoclime, Q4 2023: Lower costs set the stage for future profits
Equity Research
Ecoclime
16 feb 2024
First Impression Ecoclime, Q4 2023: Lower costs indicate rationalization
Equity Research
Ecoclime
10 nov 2023
Equity Research Ecoclime, Q3 2023: Growth continues with Evertherm
Equity Research
Ecoclime
09 nov 2023
Equity Research Ecoclime, Q3 2023: The Evertherm growth journey continues
Equity Research
Ecoclime
18 aug 2023
Research Update Ecoclime, Q2 2023: Sales growth much better than expected
Equity Research
Ecoclime
17 aug 2023
First Impression Ecoclime, Q2 2023: 34% higher revenues than expected
Equity Research
Ecoclime
15 maj 2023
Mrkt BUZZ Ecoclime: Pipe installer to continue with Evertherm under new ownership
Equity Research
Ecoclime
05 maj 2023
Research Update Ecoclime Q1 2023: Circular Energy is gathering pace
Equity Research
Ecoclime
04 maj 2023
First impression, Ecoclime Q1 2023: Higher than expected revenues, but also higher costs
Equity Research
Ecoclime
20 feb 2023
Research Update Ecoclime Q4 2022: A very strong quarter for Evertherm
Equity Research
Ecoclime
16 feb 2023
First Impression Ecoclime Q4 2022: Better than expected revenue growth
Equity Research
Ecoclime
1
2